David Moreno-Ramírez-rekin lankidetzan egindako argitalpenak (9)

2022

  1. Dermatology Care in Spanish Public Hospitals: A Mapping Study of Health Care Resources and Medical and Surgical Activity in Dermatology Departments in 2019

    Actas Dermo-Sifiliograficas, Vol. 113, Núm. 5, pp. 467-480

  2. Practical Update of the Guidelines Published by the Psoriasis Group of the Spanish Academy of Dermatology and Venereology (GPs) on the Treatment of Psoriasis With Biologic Agents: Part 2 — Management of Special Populations, Patients With Comorbid Conditions, and Risk

    Actas Dermo-Sifiliograficas, Vol. 113, Núm. 6, pp. 583-609

2021

  1. Practical update of the Recommendations Published by the Psoriasis Group of the Spanish Academy of Dermatology and Venereology (GPS) on the Treatment of Psoriasis with Biologic Therapy. Part 1. Concepts and General Management of Psoriasis with Biologic Therapy

    Actas Dermo-Sifiliograficas

2017

  1. Fiabilidad de una aplicación de ayuda a la toma de decisiones terapéuticas en el paciente con psoriasis (MDi Psoriasis®)

    Actas Dermo-Sifiliograficas, Vol. 108, Núm. 7, pp. 650-656

  2. Psoriasis moderada. Propuesta de definición

    Actas Dermo-Sifiliograficas, Vol. 108, Núm. 10, pp. 911-917

  3. Reliability of the MDi Psoriasis® Application to Aid Therapeutic Decision-Making in Psoriasis

    Actas Dermo-Sifiliograficas, Vol. 108, Núm. 7, pp. 650-656

2016

  1. Análisis de coste-efectividad y coste-utilidad de ingenol mebutato versus diclofenaco 3% e imiquimod 5% en el tratamiento de la queratosis actínica en España

    Actas Dermo-Sifiliograficas, Vol. 107, Núm. 6, pp. 498-508

  2. Genome-Wide Pathway Analysis Identifies Genetic Pathways Associated with Psoriasis

    Journal of Investigative Dermatology, Vol. 136, Núm. 3, pp. 593-602

2015

  1. Association of the PDE3A-SLCO1C1 locus with the response to anti-TNF agents in psoriasis

    Pharmacogenomics Journal, Vol. 15, Núm. 4, pp. 322-325